{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:28:40Z","timestamp":1787596120374,"version":"build-2736575974"},"reference-count":29,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>In HCV-coinfected people with HIV (PWH), there are still conflicting data regarding the long-term metabolic impact of HCV eradication. The aim of the study is to investigate long-term changes in controlled attenuation parameter (CAP) and metabolic profile after sustained virological response (SVR) post-direct acting antivirals (DAAs) in PWH. This is a retrospective observational study including individuals with HIV\/HCV coinfection, followed as outpatients at San Raffaele Hospital, who achieved SVR post-DAAs. Individuals were assessed for metabolic parameters before and after the start of DAAs. Univariate and multivariate mixed linear models were calculated to estimate crude mean changes in CAP, metabolic parameters, and weight; slopes were reported with the corresponding 95% confidence intervals (95% CI). Overall, during a median follow-up of 4.02 years (interquartile range, IQR 3.04\u20134.80), the mean percent increase in CAP was 2.86\/year (p &lt; 0. 0001), and the mean decrease in stiffness was \u20134.28 (p = 0.003). Additionally, total cholesterol (p &lt; 0.0001), high-density lipoprotein (HDL) cholesterol (p = 0.001), triglycerides (p &lt; 0.0001), glucose (p &lt; 0.0001), and Body Mass Index (BMI) (p &lt; 0.0001) increased over time. A long-term follow-up in PWH with SVR post-DAAs showed an overall significant increase in CAP and worsening of the metabolic profile, suggesting a higher risk of developing liver steatosis and metabolic alterations over time.<\/jats:p>","DOI":"10.3390\/v17070906","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:55:43Z","timestamp":1751442943000},"page":"906","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8251-6963","authenticated-orcid":false,"given":"Alessia","family":"Siribelli","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Vita-Salute San Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Diotallevi","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Galli","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0900-5639","authenticated-orcid":false,"given":"Camilla","family":"Muccini","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4891-5376","authenticated-orcid":false,"given":"Giulia","family":"Morsica","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2447-6498","authenticated-orcid":false,"given":"Riccardo","family":"Lolatto","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-3427","authenticated-orcid":false,"given":"Tommaso","family":"Clemente","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Messina","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6703-6276","authenticated-orcid":false,"given":"Costanza","family":"Bertoni","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Vita-Salute San Raffaele University, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Uberti-Foppa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Vita-Salute San Raffaele University, 20132 Milan, Italy"},{"name":"Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Castagna","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Vita-Salute San Raffaele University, 20132 Milan, Italy"},{"name":"Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Hasson","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"ref_1","unstructured":"(2024, April 09). World Health Organizations (WHO) Fact Sheet-Hepatitis, C. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/apt.15575","article-title":"Systematic review: Chronic viral hepatitis and metabolic derangement","volume":"51","author":"Wang","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/v2051195","article-title":"Lipid metabolism and HCV infection","volume":"2","author":"Boulant","year":"2010","journal-title":"Viruses"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.25501","article-title":"Role of low-density lipoprotein receptor in the hepatitis C virus life cycle","volume":"55","author":"Albecka","year":"2012","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/5584_2020_604","article-title":"Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review","volume":"1323","author":"Sagnelli","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3748\/wjg.v22.i4.1461","article-title":"Metabolic alterations and hepatitis C: From bench to bedside","volume":"22","author":"Chang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism","volume":"21","author":"Syed","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/v1020126","article-title":"Hepatitis C virus infection: Molecular pathways to steatosis, insulin resistance and oxidative stress","volume":"1","author":"Pascarella","year":"2009","journal-title":"Viruses"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hashimoto, S., Yatsuhashi, H., Abiru, S., Yamasaki, K., Komori, A., Nagaoka, S., Saeki, A., Uchida, S., Bekki, S., and Kugiyama, Y. (2016). Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163644"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"726419","DOI":"10.3389\/fimmu.2021.726419","article-title":"A Tale of Two Viruses: Immunological Insights Into HCV\/HIV Coinfection","volume":"12","author":"Gobran","year":"2021","journal-title":"Front Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/COH.0b013e32834bd365","article-title":"HIV\/hepatitis C coinfection natural history and disease progression","volume":"6","author":"Hernandez","year":"2011","journal-title":"Curr. Opin. HIV AIDS."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Graf, C., Welzel, T., Bogdanou, D., Vermehren, J., Beckel, A., Bojunga, J., Friedrich-Rust, M., Dietz, J., Kubesch, A., and Mondorf, A. (2020). Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092702"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1097\/QAD.0000000000003351","article-title":"Controlled attenuation parameter accurately detects liver steatosis in people with HIV","volume":"36","author":"Duarte","year":"2022","journal-title":"AIDS"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/apc.2018.0333","article-title":"Prevalence and Predictors of Hepatic Steatosis in Patients with HIV\/HCV Coinfection and the Impact of HCV Eradication","volume":"33","author":"Chromy","year":"2019","journal-title":"AIDS Patient Care STDS"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40265-016-0685-x","article-title":"Genotype 3 Infection: The Last Stand of Hepatitis C Virus","volume":"77","author":"Chan","year":"2017","journal-title":"Drugs"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Siphepho, P.Y., Liu, Y.T., Shabangu, C.S., Huang, J.F., Huang, C.F., Yeh, M.L., Yu, M.L., and Wang, S.C. (2021). The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101491"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-09588-w","article-title":"Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis","volume":"12","author":"Sheridan","year":"2022","journal-title":"Sci Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5604\/01.3001.0010.7536","article-title":"Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment","volume":"17","author":"Gitto","year":"2018","journal-title":"Ann. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Spaziante, M., Taliani, G., Marchetti, G., Tavelli, A., Lichtner, M., Cingolani, A., Cicalini, S., Biliotti, E., Girardi, E., and Antinori, A. (2021). Impact of HCV Eradication on Lipid Metabolism in HIV\/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study. Viruses, 13.","DOI":"10.3390\/v13071402"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chuaypen, N., Siripongsakun, S., Hiranrat, P., Tanpowpong, N., Avihingsanon, A., and Tangkijvanich, P. (2022). Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0269641"},{"key":"ref_22","first-page":"305","article-title":"Hepatitis C virus infection and nonalcoholic steatohepatitis","volume":"8","author":"Patel","year":"2012","journal-title":"Gastroenterol Hepatol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-93251-3","article-title":"Serum lipid profile in HCV patients treated with direct-acting antivirals: A systematic review and meta-analysis","volume":"11","author":"Villani","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1590\/S0066-782X2009001100019","article-title":"Metabolic abnormalities, antiretroviral therapy and cardiovascular disease in elderly patients with HIV","volume":"93","author":"Kramer","year":"2009","journal-title":"Arq Bras Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-3542(01)00148-6","article-title":"Metabolic complications associated with antiretroviral therapy","volume":"51","author":"Jain","year":"2001","journal-title":"Antivir. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/infdis\/jix517","article-title":"No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV","volume":"217","author":"Chaudhury","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/QAD.0000000000001345","article-title":"Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults","volume":"31","author":"Reid","year":"2017","journal-title":"AIDS"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/7\/906\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:59:34Z","timestamp":1760032774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/7\/906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["v17070906"],"URL":"https:\/\/doi.org\/10.3390\/v17070906","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}